Compass therapeutics to participate in upcoming investor events

Boston, sept. 03, 2024 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in the following investor events during the month of september 2024.
CMPX Ratings Summary
CMPX Quant Ranking